NHMRC Glaucoma Guidelines - ANZGIG
NHMRC Glaucoma Guidelines - ANZGIG
NHMRC Glaucoma Guidelines - ANZGIG
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>NHMRC</strong> GUIDELINES FOR THE SCREENING, PROGNOSIS, DIAGNOSIS, MANAGEMENT AND PREVENTION OF GLAUCOMA<br />
Chapter 6 – Identifying those at risk of developing glaucoma<br />
Hatt S, Wormald R, Burr J (2006): Screening for prevention of optic nerve damage due to chronic<br />
open angle glaucoma. Cochrane Database of Systematic Reviews; 4.<br />
Japanese <strong>Glaucoma</strong> Society [JGS] (2004): <strong>Guidelines</strong> for glaucoma. Tokyo: Japanese <strong>Glaucoma</strong> Society.<br />
Leone FT, Fish JE, Szefler SJ, West SL (2003): Systematic review of the evidence regarding potential<br />
complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest<br />
Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of<br />
Allergy, Asthma, and Immunology. Chest; 124 (6):2329-2340.<br />
Leske MC, Heijl A, Hyman L, Bengtsson B, Komaroff E (2004): Factors for progression and glaucoma<br />
treatment: The Early Manifest <strong>Glaucoma</strong> Trial. Current Opinion in Ophthalmology; 15:102–106.<br />
Mackey DA, Craig JE (2003): Predictive DNA testing for glaucoma: reality in 2003. Ophthalmology<br />
Clinics in North America; 16:639-45.<br />
Madden AC, Simmons D, McCarty CA, Khan MA, Taylor HR (2002): Eye health in rural Australia.<br />
Clinical and Experimental Ophthalmology; 30(5):316-321.<br />
Maier PC, Funk J, Schwarzer G, Antes G, Falck-Ytter YT (2005): Treatment of ocular hypertension<br />
and open angle glaucoma: meta-analysis of randomised controlled trials. British Medical Journal;<br />
331(7509):134.<br />
Mansberger SL, Cioffi GA (2006): The Probability of <strong>Glaucoma</strong> From Ocular Hypertension<br />
Determined by Ophthalmologists in Comparison to a Risk Calculator. Journal of <strong>Glaucoma</strong>;<br />
15(5):426-431.<br />
Medeiros FA, Zangwill LM, Bowd C, Vasile C, Sample PA, Weinreb RN (2007): Agreement between<br />
stereophotographic and confocal scanning laser ophthalmoscopy measurements of cup/disc ratio:<br />
effect on a predictive model for glaucoma development. Journal of <strong>Glaucoma</strong>; 16(2):209-14.<br />
Mitchell P, Smith W, Attebo K, Healey P (1996): Prevalence of open-angle glaucoma in Australia:<br />
the Blue Mountains eye study. Ophthalmology; 103(10):1661-1669.<br />
Royal College of Ophthalmologists [RCO] (2004): <strong>Guidelines</strong> for the management of open angle<br />
glaucoma and ocular hypertension. London: Royal College of Ophthalmologists.<br />
Schmier JK, Halpern MT, Jones ML (2007): The economic implications of glaucoma – A literature<br />
review. PharmacoEconomics; 25(4): 287-308.<br />
Sommer A, Katz J, Quigley HA, et al. Clinically detectable nerve fiber layer atrophy precedes the<br />
onset of glaucomatous field loss. Archives of Ophthalmology 1991; 109:77-83.<br />
South-East Asia <strong>Glaucoma</strong> Interest Group [SEAGIG] (2003): Asia Pacific <strong>Glaucoma</strong> <strong>Guidelines</strong>.<br />
Sydney: South-East Asia <strong>Glaucoma</strong> Interest Group.<br />
Taylor HR, Xie J, Fox S, Dunn RA, Arnold AL, Keefe JE (2010): The prevalence and causes of vision<br />
loss in Indigenous Australians: the National Indigenous Eye Health Survey. Medical Journal of<br />
Australia; 192: 312-318.<br />
Tielsch JM, Katz J, Singh K, Quigley HA, Gottsch JD, Javitt J, Sommer A (1991): A Population-based<br />
Evaluation of <strong>Glaucoma</strong> Screening: The Baltimore Eye Survey. American Journal of Epidemiology;<br />
134(10): 1102-1110.<br />
Tripathi RC, Tripathi BJ, Haggerty C (2003): Drug-Induced <strong>Glaucoma</strong>s Mechanism and Management.<br />
Drug Safety; 26(11): 749-767.<br />
62 National Health and Medical Research Council